This inventor holds 1 USPTO granted patent. Top assignees: Shandong Xinhua Pharmaceutical Co., Ltd., Shenyang Pharmaceutical University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jinheng Gao: Innovator in Octahydroanthracene Compounds
Jinheng Gao is a notable inventor based in Shenyang, China. He has made significant contributions to the field of chemistry, particularly in the development of octahydroanthracene compounds. His work focuses on the therapeutic applications of these compounds, which have shown promise in treating tumors and neurodegenerative diseases.
Latest Patents
Jinheng Gao holds a patent for an octahydroanthracene compound, which includes a detailed preparation method and its applications. The patent describes an octahydroanthracene compound characterized by specific structural formulas. The preparation method primarily involves using benzene as a starting material, followed by a series of chemical reactions including Friedel-Crafts reaction, nitration, reduction, and amide formation. This innovative compound has demonstrated a good therapeutic effect on various medical conditions.
Career Highlights
Throughout his career, Jinheng Gao has worked with reputable organizations such as Shandong Xinhua Pharmaceutical Co., Ltd. and Shenyang Pharmaceutical University. His experience in these institutions has allowed him to advance his research and contribute to the pharmaceutical industry significantly.
Collaborations
Jinheng Gao has collaborated with esteemed colleagues, including Guoliang Chen and Zhonghui Zheng. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Jinheng Gao's contributions to the development of octahydroanthracene compounds highlight his innovative spirit and dedication to advancing medical science. His work not only showcases his expertise but also holds the potential to improve therapeutic options for patients suffering from serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile